Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN
#Weekly digest
The Saturday roundup format.
Expert digest
What experts said about CJC-1295 in Q2 2026
On-record expert commentary on CJC-1295 from Q2 2026: the evidence gap, cancer-risk concerns, regulatory shifts, and the upcoming PCAC review.
Expert digest
Ipamorelin: what experts said, Q2 2026
On-record expert commentary on ipamorelin from Q2 2026, with credentials, conflicts of interest, and the FDA regulatory picture.
Expert digest
What experts said about PT-141 in Q2 2026
On-record expert commentary on PT-141 from Q2 2026: arguments for male trials, a Harvard meta-analysis, and Palatin's obesity pivot.